Published in West J Med on May 01, 1983
Use of antibiotics. A brief exposition of the problem and some tentative solutions. Ann Intern Med (1973) 4.07
Randomised controlled trial of antibiotics in patients with cough and purulent sputum. Br Med J (1976) 3.57
Drug prescribing and use in an American community. Ann Intern Med (1972) 3.55
The protean manifestations of Mycoplasma pneumoniae infection in adults. Am J Med (1975) 3.06
Sinusitis of the maxillary antrum. N Engl J Med (1975) 2.57
Adult pneumonia in a general hospital. Etiology and host risk factors. Arch Intern Med (1972) 2.24
Cutaneous abscesses. Anaerobic and aerobic bacteriology and outpatient management. Ann Intern Med (1977) 2.08
Antibiotic usage in seven community hospitals. JAMA (1970) 1.82
Etiology and antimicrobial therapy of acute maxillary sinusitis. J Infect Dis (1979) 1.52
Group A streptococci, mycoplasmas, and viruses associated with acute pharyngitis. JAMA (1967) 1.47
Haemophilus influenzae pneumonia in adults. JAMA (1977) 1.41
Group A streptococcal infections of the skin and pharynx (second of two parts). N Engl J Med (1977) 1.39
Percutaneous transtracheal aspiration in the diagnosis of anaerobic pulmonary infection. Ann Intern Med (1973) 1.32
Antibiotic use at Duke University Medical Center. JAMA (1977) 1.31
Bacteria, viruses, and mycoplasmas in acute pneumonia in adults. Am Rev Respir Dis (1971) 1.29
A study of antimicrobial misuse in a university hospital. Am J Med Sci (1978) 1.25
The value of the sputum gram's stain in community-acquired pneumonia. JAMA (1982) 1.14
Acute otitis media. Etiological and therapeutical aspects on acute otitis media. Pract Otorhinolaryngol (Basel) (1971) 0.93
Cellulitis: a prospective study. Ann Emerg Med (1980) 0.87
Health and disease in the United States. Annu Rev Public Health (1980) 0.79
Cephalosporin cost reduction. Hosp Formul (1981) 0.77
Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians. JAMA (1997) 8.24
Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis. JAMA (1998) 8.02
Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome. N Engl J Med (1992) 6.30
Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N Engl J Med (1989) 6.29
A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptoccal meningitis. N Engl J Med (1979) 5.87
Cocaine use and HIV infection in intravenous drug users in San Francisco. JAMA (1989) 5.66
Effect of probenecid on cerebrospinal fluid concentrations of penicillin and cephalosporin derivatives. Antimicrob Agents Chemother (1974) 5.19
Sexual harassment in medical training. N Engl J Med (1993) 4.93
Species-specific resistance to antimocrobial synergism in Streptococcus faecium and Streptococcus faecalis. J Infect Dis (1979) 4.70
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study. Leukemia (2011) 4.47
Bacterial adherence in the pathogenesis of endocarditis. Interaction of bacterial dextran, platelets, and fibrin. J Clin Invest (1978) 4.38
Role of toxigenic and invasive bacteria in acute diarrhea of childhood. N Engl J Med (1975) 4.23
Principles of appropriate antibiotic use for acute pharyngitis in adults: background. Ann Intern Med (2001) 3.75
Antimicrobial therapy of experimental endocarditis caused by Staphylococcus aureus. J Infect Dis (1975) 3.52
A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma. Br J Haematol (2004) 3.49
Spread of Streptococcus pneumoniae in families. I. Carriage rates and distribution of types. J Infect Dis (1975) 3.33
Principles of appropriate antibiotic use for acute rhinosinusitis in adults: background. Ann Intern Med (2001) 3.15
Combination antibiotic therapy of bacterial endocarditis. Ann Intern Med (1980) 3.03
Excessive antibiotic use for acute respiratory infections in the United States. Clin Infect Dis (2001) 2.87
Endocarditis due to methicillin-resistant Staphylococcus aureus in rabbits: expression of resistance to beta-lactam antibiotics in vivo and in vitro. J Infect Dis (1984) 2.77
Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection. N Engl J Med (1991) 2.77
Condom use in multi-ethnic neighborhoods of San Francisco: the population-based AMEN (AIDS in Multi-Ethnic Neighborhoods) Study. Am J Public Health (1992) 2.71
Penicillin-aminoglycoside synergy in experimental Streptococcus viridans endocarditis. J Infect Dis (1974) 2.64
NAD(P)H:quinone oxidoreductase 1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphisms. Chem Biol Interact (2000) 2.60
Community-acquired bacteremia in patients with acquired immunodeficiency syndrome: clinical presentation, bacteriology, and outcome. Am J Med (1989) 2.58
Sinusitis of the maxillary antrum. N Engl J Med (1975) 2.57
Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: A prospective study. Ann Intern Med (1982) 2.52
First direct observation of a nearly ideal graphene band structure. Phys Rev Lett (2009) 2.41
Risk of transmitting the human immunodeficiency virus, cytomegalovirus, and hepatitis B virus to health care workers exposed to patients with AIDS and AIDS-related conditions. J Infect Dis (1987) 2.32
International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma. Leukemia (2009) 2.28
Treatment of right-sided Staphylococcus aureus endocarditis in intravenous drug users with ciprofloxacin and rifampicin. Lancet (1989) 2.18
Principles of appropriate antibiotic use for treatment of acute respiratory tract infections in adults: background, specific aims, and methods. Ann Intern Med (2001) 2.17
Infectious complications with respiratory pathogens despite ciprofloxacin therapy. N Engl J Med (1991) 2.12
Effects of ampicillin and corticosteroids on brain water content, cerebrospinal fluid pressure, and cerebrospinal fluid lactate levels in experimental pneumococcal meningitis. J Infect Dis (1985) 2.10
Natural history of disseminated Mycobacterium avium complex infection in AIDS. J Infect Dis (1991) 2.07
The HIV epidemic and training in internal medicine. Challenges and recommendations. N Engl J Med (1989) 2.06
Uncomplicated acute bronchitis. Ann Intern Med (2000) 2.06
Spread of Streptococcus pneumoniae in families. II. Relation of transfer of S. pneumoniae to incidence of colds and serum antibody. J Infect Dis (1975) 2.05
A randomized comparison of the safety and efficacy of once-daily gentamicin or thrice-daily gentamicin in combination with ticarcillin-clavulanate. Am J Med (1998) 2.04
Antimicrobial treatment of infective endocarditis due to viridans streptococci, enterococci, and staphylococci. JAMA (1989) 2.03
Antibacterial activity of beta-lactam antibiotics in experimental meningitis due to Streptococcus pneumoniae. J Infect Dis (1984) 2.00
NAD(P)H:Quinone oxidoreductase activity is the principal determinant of beta-lapachone cytotoxicity. J Biol Chem (2000) 1.99
Methods to improve detection of pneumococci in respiratory secretions. J Clin Microbiol (1975) 1.94
Bactericidal versus bacteriostatic antibiotic therapy of experimental pneumococcal meningitis in rabbits. J Clin Invest (1983) 1.93
Single, large, daily dosing versus intermittent dosing of tobramycin for treating experimental pseudomonas pneumonia. J Infect Dis (1988) 1.90
Role of the vegetation in experimental Streptococcus viridans endocarditis. Infect Immun (1974) 1.89
Total therapy with tandem transplants for newly diagnosed multiple myeloma. Blood (1999) 1.89
Principles of appropriate antibiotic use for treatment of nonspecific upper respiratory tract infections in adults: background. Ann Intern Med (2001) 1.89
In vitro susceptibility studies with josamycin and erythromycin. Antimicrob Agents Chemother (1976) 1.89
Multiple use of disposable insulin syringe-needle units. JAMA (1980) 1.89
Routine use of anaerobic blood cultures: are they still indicated? Am J Med (2000) 1.88
Therapy of cryptococcosis with a combination of flucytosine and amphotericin B. J Infect Dis (1975) 1.88
Comparative pharmacology of cefaclor and cephalexin. Antimicrob Agents Chemother (1977) 1.86
Pefloxacin therapy for experimental endocarditis caused by methicillin-susceptible or methicillin-resistant strains of Staphylococcus aureus. Antimicrob Agents Chemother (1985) 1.85
Opportunistic pneumonia: a clinicopathological study of five cases caused by an unidentified acid-fast bacterium. N Engl J Med (1979) 1.84
Teicoplanin versus nafcillin and vancomycin in the treatment of experimental endocarditis caused by methicillin-susceptible or -resistant Staphylococcus aureus. Antimicrob Agents Chemother (1984) 1.75
Antimicrobial therapy of experimental enterococcal endocarditis. Antimicrob Agents Chemother (1975) 1.75
Nafcillin-gentamicin synergism in experimental staphylococcal endocarditis. J Lab Clin Med (1976) 1.73
Experimental pneumococcal meningitis: role of leukocytes in pathogenesis. Infect Immun (1983) 1.72
Serum bactericidal activity of rifampin in combination with other antimicrobial agents against Staphylococcus aureus. Antimicrob Agents Chemother (1986) 1.70
Management of treatment-emergent peripheral neuropathy in multiple myeloma. Leukemia (2011) 1.70
Oligoclonal protein bands and Ig isotype switching in multiple myeloma treated with high-dose therapy and hematopoietic cell transplantation. Blood (1998) 1.68
Cephalosporin antibiotics in therapy of experimental Streptococcus pneumoniae and Haemophilus influenzae meningitis in rabbits. J Infect Dis (1978) 1.68
The postantibiotic effect in the treatment of experimental meningitis caused by Streptococcus pneumoniae in rabbits. J Infect Dis (1984) 1.67
Candida albicans endocarditis: ultrastructural studies of vegetation formation. Infect Immun (1978) 1.66
Failure of a once-daily regimen of cefonicid for treatment of endocarditis due to Staphylococcus aureus. Rev Infect Dis (1985) 1.66
Pharmacokinetics of cefoperazone in normal volunteers and subjects with renal insufficiency. Antimicrob Agents Chemother (1981) 1.66
New cephalosporins cefotaxime, cefpimizole, BMY 28142, and HR 810 in experimental pneumococcal meningitis in rabbits. Antimicrob Agents Chemother (1985) 1.66
Cerebrospinal fluid outflow resistance in rabbits with experimental meningitis. Alterations with penicillin and methylprednisolone. J Clin Invest (1980) 1.64
Treatment of streptomycin-susceptible and streptomycin-resistant enterococcal endocarditis. Ann Intern Med (1984) 1.64
Regulation of IFN-gamma induction in human peripheral blood cells by exogenous and endogenously produced interleukin 2. J Immunol (1985) 1.62
The impact of diuretic therapy on reported sexual function. Arch Intern Med (1991) 1.61
Vertebral artery dissection and pontine infarct after chiropractic manipulation. Am J Emerg Med (2001) 1.60
DT-diaphorase in activation and detoxification of quinones. Bioreductive activation of mitomycin C. Cancer Metastasis Rev (1993) 1.58
Nicaragua: a health system developing under conditions of war. Int J Health Serv (1987) 1.57
Response to therapy in an experimental rabbit model of meningitis due to Listeria monocytogenes. J Infect Dis (1979) 1.57
Experimental Candida albicans endocarditis: characterization of the disease and response to therapy. Infect Immun (1977) 1.56
Value of serum tests in combined drug therapy of endocarditis. Antimicrob Agents Chemother (1983) 1.56
Principles of appropriate antibiotic use for treatment of uncomplicated acute bronchitis: background. Ann Intern Med (2001) 1.55
Sustained bacteremia in patients with prosthetic cardiac valves. N Engl J Med (1972) 1.54
Etiology and antimicrobial therapy of acute maxillary sinusitis. J Infect Dis (1979) 1.52
Moxalactam and cefazolin: comparative pharmacokinetics in normal subjects. Antimicrob Agents Chemother (1981) 1.51
In vitro susceptibility studies with cefaclor and cephalexin. Antimicrob Agents Chemother (1977) 1.51
Intermittent or continuous therapy of experimental meningitis due to Streptococcus pneumoniae in rabbits: preliminary observations on the postantibiotic effect in vivo. Rev Infect Dis (1981) 1.49
Comparative pharmacology of josamycin and erythromycin stearate. Antimicrob Agents Chemother (1976) 1.46
Cefamandole and ampicillin therapy in experimental Haemophilus influenzae meningitis. J Infect Dis (1977) 1.46
Tissue factor is a major stimulus for vegetation formation in enterococcal endocarditis in rabbits. J Clin Invest (1984) 1.46
Aminophylline increases the toxicity but not the efficacy of an inhaled beta-adrenergic agonist in the treatment of acute exacerbations of asthma. Am Rev Respir Dis (1985) 1.44
Characterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase). Br J Cancer (1997) 1.42
Antiendotoxin monoclonal antibodies for gram-negative sepsis: guidelines from the IDSA. Clin Infect Dis (1992) 1.41
Effect of fibronectin on adherence of Staphylococcus aureus to fibrin thrombi in vitro. Infect Immun (1985) 1.40
Staphylococcus aureus endocarditis: clinical manifestations in addicts and nonaddicts. Medicine (Baltimore) (1983) 1.39
Antibiotic therapy of bacterial meningitis: lessons we've learned. Am J Med (1981) 1.38
Elevated DT-diaphorase activity and messenger RNA content in human non-small cell lung carcinoma: relationship to the response of lung tumor xenografts to mitomycin Cł. Cancer Res (1992) 1.38
Principles of appropriate antibiotic use for treatment of uncomplicated acute bronchitis: background. Ann Emerg Med (2001) 1.37
The utility of follow-up testing after curative cancer therapy. A critical review and economic analysis. J Gen Intern Med (1997) 1.37
Correlation of in vitro time-kill curves and kinetics of bacterial killing in cerebrospinal fluid during ceftriaxone therapy of experimental Escherichia coli meningitis. Antimicrob Agents Chemother (1983) 1.37
Influence of preformed antibody on experimental Streptococcus sanguis endocarditis. Infect Immun (1979) 1.36
Factors influencing the therapy of experimental Proteus mirabilis meningitis in rabbits. J Infect Dis (1978) 1.36
Risk for AIDS in multiethnic neighborhoods in San Francisco, California. The population-based AMEN Study. West J Med (1992) 1.35